Business · 1 sources covering this

Sun Pharma Shares In Focus: US MFN Deal Eases Tariff Risk, Says ICICI Securities — Check Target Price

While Sun Pharma's specialty portfolio is now safeguarded from tariffs, the same safeguard must be extended to Organon post-acquisition, adds the brokerage.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Sun Pharma Shares In Focus: US MFN Deal Eases Tariff Risk, Says ICICI Securities — Check Target Price
While Sun Pharma's specialty portfolio is now safeguarded from tariffs, the same safeguard must be extended to Organon post-acquisition, adds the brokerage.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/162f17833f364b12e946e1bcade3e854157c5695"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Sun Pharma Shares In Focus: US MFN Deal Eases Tariff Risk, Says ICICI Securities — Check Target Price"></iframe>

Sun Pharma Shares In Focus: US MFN Deal Eases Tariff Risk, Says ICICI Securities — Check Target Price

How 1 sources are covering this

Sun Pharma Shares In Focus: US MFN Deal Eases Tariff Risk, Says ICICI Securities — Check Target Price

More from Business

AI-generated work can be original, so why can't AI be its author?

Plea mentioned in SC challenging Neet-PG re-examination for 2,445 students

Google's September Android Drop brings Motion Assist and more Gemini tricks

OpenAI says Apple has only itself to blame in trade-secret fight

Reader

Trust & legal

Across the network